Related Experiment Video
Updated: May 7, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 16, 2013
Differential effects of PDE4 inhibitors on cortical neurons and T-lymphocytes
Ryo Hirose1, Haruhiko Manabe, Koji Yanagawa
1Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., Nagaizumi-cho, Shizuoka, Japan. ryou.hirose@kyowa.co.jp
Abstract:
Inhibitors of PDE4 (cAMP-specific phosphodiesterase) induce side effects, including nausea and emesis, that limit their therapeutic potential. We investigated the function of two catalytically active conformations of PDE4 (a low-affinity conformer detected by conventional cAMP hydrolytic activity and a high-affinity conformer detected by [(3)H]rolipram binding) in neuronal cells. We assessed enhancement of beta-adrenoceptor-mediated cAMP accumulation in cortical neurons in vitro by eleven PDE4 inhibitors with diverse biochemical profiles. The compounds tested have a wide inhibition range of PDE4 catalytic activity and [(3)H]rolipram binding. Inhibition potency for PDE4 catalytic activity and [(3)H]rolipram binding for each compound was different. Potency in augmentation of cAMP correlated significantly with the inhibitory effect on [(3)H]rolipram binding, but not with that against PDE4 catalytic activity. On the other hand, the inhibitory effect on proliferation of T-lymphocytes of the same PDE4 inhibitors correlated both with inhibition of PDE4 catalytic activity and with inhibition of [(3)H]rolipram binding. These findings indicate that the high affinity PDE4 conformer exists at a high level in cortical neurons and is important in the regulation of cAMP. Furthermore, the relative contributions of the two PDE4 conformers in cell function may cause different PDE4 inhibitor effects on cortical neurons and T-lymphocytes.
Insights
Phosphodiesterase 4 (PDE4) inhibitors targeting high-affinity PDE4 conformers in neurons are more effective for increasing cAMP levels. This suggests distinct PDE4 conformer roles in neuronal and immune cells.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Phosphodiesterase 4 (PDE4) inhibitors are limited by side effects like nausea and emesis.
- PDE4 exists in at least two catalytically active conformations: low-affinity and high-affinity.
- Understanding these conformations is crucial for developing targeted therapeutics.
Purpose of the Study:
- To investigate the functional roles of PDE4's low- and high-affinity conformations in neuronal cells.
- To determine which PDE4 conformation is targeted by various inhibitors in cortical neurons.
- To compare the effects of PDE4 inhibitors on neuronal cells versus T-lymphocytes.
Main Methods:
- Assessed enhancement of beta-adrenoceptor-mediated cAMP accumulation in cortical neurons using eleven PDE4 inhibitors.
- Measured PDE4 catalytic activity and [(3)H]rolipram binding for each inhibitor.
- Evaluated the inhibitory effect of PDE4 inhibitors on T-lymphocyte proliferation.
Main Results:
- Potency of cAMP augmentation in neurons correlated with inhibition of high-affinity PDE4 binding ([(3)H]rolipram), not catalytic activity.
- Inhibition of T-lymphocyte proliferation correlated with inhibition of both PDE4 catalytic activity and high-affinity binding.
- Significant differences in inhibitor efficacy were observed between neuronal cells and T-lymphocytes.
Conclusions:
- The high-affinity PDE4 conformer is abundant in cortical neurons and critical for cAMP regulation.
- Differential engagement of PDE4 conformers by inhibitors explains varied effects on neuronal and immune cells.
- Targeting the high-affinity PDE4 conformation may offer a more selective therapeutic approach for neurological conditions.
More Related Videos
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Drugs Affecting Neurotransmitter Synthesis
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Pharmacodynamic Responses: Different Types

